A surprising new study found that the controversial antimalarial drug hydroxychloroquine helped Covid-19 patients better survive in the hospital.
A surprising new study found that the controversial antimalarial drug hydroxychloroquine helped patients better survive in the hospital.
A team at Henry Ford Health System in Southeast Michigan said Thursday its study of 2,541 hospitalized patients found that those given hydroxychloroquine were much less likely to die. Dr. Marcus Zervos, division head of infectious disease for Henry Ford Health System, said 26% of those not given hydroxychloroquine died, compared to 13% of those who got the drug. The team looked back at everyone treated in the hospital system since the first patient in March.
Trump's history of promoting hydroxychloroquine 01:47It's a surprising finding because several other studies have found no benefit from hydroxychloroquine, a drug originally developed to treat and prevent malaria. President Donald Trump touted the drug heavily, but later studies found not only did patients not do better if they got the drug, they were more likely to suffer cardiac side effects.
Gupta says Trump should not be taking hydroxychloroquine 02:44The Henry Ford team also monitored patients carefully for heart problems, he said."The combination of hydroxychloroquine plus azithromycin was reserved for selected patients with severe COVID-19 and with minimal cardiac risk factors," the team wrote. The Henry Ford team said they believe their findings show hydroxychloroquine could be potentially useful as a treatment for coronavirus.
But a White House official praised the Henry Ford team's study. Peter Navarro, the White House trade adviser, said the study shows hydroxychloroquine works if given early enough. "This is a big deal," he told CNN."This medicine can literally save tens of thousands, perhaps hundreds of thousands of American lives and maybe millions of people worldwide."
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19 vaccine from Pfizer and BioNTech shows 'encouraging' data in early studyA Covid-19 vaccine candidate has yielded positive data in early tests, according to findings released by US drugmaker Pfizer and Germany's BioNTech. Follow live updates:
Read more »
U.S. COVID-19 deaths likely higher than reported, study showsThe number of Americans who died from COVID-19 in March through May was likely significantly higher than the official U.S. count due in part to state-level reporting discrepancies, according to a study published on Wednesday.
Read more »
COVID-19 deaths in the U.S. may be 28% higher than official count, study estimatesResearchers calculate that there were 122,300 more deaths in the U.S. in March, April and May this year than are typically seen during that three-month period.
Read more »
COVID-19 strain in Beijing outbreak may have come from Southeast Asia: Harvard studyA strain of COVID-19 that has infected more than 300 people in Beijing since early June could have originated in South or Southeast Asia, according to a study by Harvard University researchers.
Read more »
Demand for dexamethasone rises after study finds COVID-19 benefits, FDA data showsA steroid that was in shortage before the pandemic has gotten more scarce since researchers reported it can improve the survival rate of COVID-19 patients.
Read more »
Only 9% of Brazil's COVID-19 cases are asymptomatic, study showsLess than 10% of people infected with the novel coronavirus in Brazil were asymptomatic and the majority of those who tested positive for the COVID-19 respiratory disease had mild symptoms, a survey of almost 90,000 people from all regions showed on Thursday.
Read more »